NEW ORLEANS — Advancements in laser technology have opened the door to new treatment options for acne patients, according to a presenter at the American Academy of Dermatology Annual Meeting.Prior to recent years, lasers were not an integral part of acne treatment due to a lack of efficiency, according to Emmy M. Graber, MD, MBA, FAAD, president and founder of The Dermatology Institute of
06.07.2022 - Mr. Larsen brings over 40 years of medical device industry experience and skills strongly aligned with the Company’s strategy to strengthen corporate governanceATLANTA, July 06, 2022 (GLOBE NEWSWIRE) - Femasys Inc. (NASDAQ: FEMY), a biomedical . Seite 1
Published: Mar 03, 2021
MALVERN, Pa., March 03, 2021 (GLOBE NEWSWIRE) Neuronetics, Inc.. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced Cory Anderson has been appointed the company’s Vice President, Clinical Affairs and Medical Operations effective as of March 1.
“I am excited to welcome Cory to the team and know he’ll make an impact quickly,” said Keith J. Sullivan, President and Chief Executive Officer of Neuronetics, Inc. “We’re laser focused on driving clinical innovation to ensure the millions suffering from depression and other conditions have access to the treatments and support they need, and Cory shares that commitment.”
Neuronetics Names Cory Anderson Vice President, Clinical Affairs and Medical Operations Company focuses on driving clinical development for NeuroStar® Advanced Therapy System for mental health
March 03, 2021 08:00 ET | Source: Neuronetics Neuronetics Malvern, Pennsylvania, UNITED STATES
MALVERN, Pa., March 03, 2021 (GLOBE NEWSWIRE) Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced Cory Anderson has been appointed the company’s Vice President, Clinical Affairs and Medical Operations effective as of March 1.
“I am excited to welcome Cory to the team and know he’ll make an impact quickly,” said Keith J. Sullivan, President and Chief Executive Officer of Neuronetics, Inc. “We’re laser focused on driving clinical innova